Generation Bio Co Quick Ratio (GBIO) starting from the third quarter 2025 to third quarter 2024, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Quick Ratio
• Working Capital
• LT Debt to Equity
• Debt to Equity
• Leverage Ratio
• Tangible Leverage
• Interest Coverage
• Debt Coverage
• Work. Cap. Per Revenue
Generation Bio Co   (NASDAQ: GBIO)

Generation Bio Co 's Quick Ratio

GBIO's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


In the wake of the increase in Current Liabilities in the third quarter 2025, Quick Ratio fell to 4.26 a new company low.

Within Major Pharmaceutical Preparations industry 182 other companies have achieved higher Quick Ratio than Generation Bio Co in third quarter 2025. While Quick Ratio total ranking in the third quarter 2025 has deteriorated compared to the prior quarter from 355 to 599.

Explain Quick Ratio?
How much Cash & cash equivalents GBIO´s has?
What are GBIO´s Current Liabilities?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

GBIO Quick Ratio (Sep 30 2025)
Q3		 (Jun 30 2025)
Q2		 (Mar 31 2025)
Q1		 (Dec 31 2024)
Q4		 (Sep 30 2024)
Q3
Y / Y Current Liabilities Change -30.25 % -35.65 % -30.78 % -12.17 % -8.09 %
Y / Y Cash & cash equivalent Change -51.5 % -34.84 % -28.15 % -29.94 % -36.51 %
Quick Ratio MRQ 4.26 7.3 8.04 5.28 6.13
GBIO's Total Ranking # 599 # 355 # 374 # 545 # 350
Seq. Current Liabilities Change 8.62 % -1.16 % -44.1 % 16.21 % 0.21 %
Seq. Cash & cash equivalent Change -36.6 % -10.28 % -14.94 % 0.25 % -14.83 %



Quick Ratio third quarter 2025 Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 183
Healthcare Sector # 301
Overall Market # 599


Quick Ratio Statistics
High Average Low
41.79 16.33 4.26
(Mar 31 2021)   (Sep 30 2025)




Financial Statements
Generation Bio Co 's Current Liabilities $ 21 Millions Visit GBIO's Balance sheet
Generation Bio Co 's Cash & cash equivalent $ 90 Millions Visit GBIO's Balance sheet
Source of GBIO's Sales Visit GBIO's Sales by Geography


Cumulative Generation Bio Co 's Quick Ratio

GBIO's Quick Ratio for the trailling 12 Months

GBIO Quick Ratio

 (Sep 30 2025)
12 Months		 (Jun 30 2025)
12 Months		 (Mar 31 2025)
12 Months		 (Dec 31 2024)
12 Months		 (Sep 30 2024)
12 Months
Y / Y Current Liabilities TTM Growth -26.02 % -20.56 % -9.88 % 1.38 % 26.99 %
Y / Y Cash & cash equivalent TTM Growth -35.2 % -32.54 % -31.62 % -30.39 % -24.51 %
Quick Ratio TTM 6.04 6.42 6.48 6.52 6.89
Total Ranking TTM # 2978 # 2789 # 3013 # 2741 # 2999
Seq. Current Liabilities TTM Growth -8.76 % -9.34 % -7.05 % -3.78 % -2.02 %
Seq. Cash & cash equivalent TTM Growth -14.22 % -10.15 % -7.66 % -8.94 % -10.72 %

Quick ratio ranking by company, industry and sector >> Back to GBIO Financial Strength Comparisons >> Go to Compare GBIO Quick Ratio to its Competitors

On the trailing twelve months basis In spite of the year on year decrease in GBIO's Current Liabilities to $21.04 millions, cumulative Quick Ratio to 6.04 below the GBIO average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Major Pharmaceutical Preparations industry 414 other companies have achieved higher Quick Ratio than Generation Bio Co . While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the second quarter 2025 from 2789 to 2978.

Explain Quick Ratio?
How much Cash & cash equivalents GBIO´s has?
What are GBIO´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Major Pharmaceutical Preparations Industry # 415
Healthcare Sector # 843
Within the Market # 2978


trailing twelve months Quick Ratio Statistics
High Average Low
31.46 16.02 6.04
(Jun 30 2021)   (Sep 30 2025)




Companies with similar Quick Ratio in the quarter ending Sep 30 2025, within Major Pharmaceutical Preparations Industry Quick RatioSep 30 2025 MRQ Cash & cash equivalentSep 30 2025 MRQ Current Liabilities
Unicycive Therapeutics Inc  11.48 $ 42.695  Millions$ 3.719  Millions
Onkure Therapeutics Inc   11.26 $ 70.331  Millions$ 6.247  Millions
Palvella Therapeutics Inc   11.16 $ 63.567  Millions$ 5.697  Millions
Connect Biopharma Holdings Limited  11.02 $ 37.850  Millions$ 3.436  Millions
Harmony Biosciences Holdings inc   10.83 $ 672.581  Millions$ 62.101  Millions
Diamedica Therapeutics Inc   10.76 $ 55.518  Millions$ 5.159  Millions
Anebulo Pharmaceuticals Inc   10.74 $ 10.355  Millions$ 0.964  Millions
Nuvalent Inc   10.58 $ 943.103  Millions$ 89.151  Millions
Spyre Therapeutics Inc   10.51 $ 486.198  Millions$ 46.274  Millions
Pmv Pharmaceuticals Inc   10.50 $ 129.250  Millions$ 12.304  Millions
Cartesian Therapeutics Inc   10.39 $ 143.384  Millions$ 13.803  Millions
Eledon Pharmaceuticals Inc   10.34 $ 183.132  Millions$ 17.718  Millions
Erasca Inc   10.04 $ 288.400  Millions$ 28.712  Millions
Lyell Immunopharma Inc   10.03 $ 319.624  Millions$ 31.878  Millions
Edesa Biotech Inc   10.01 $ 10.800  Millions$ 1.079  Millions
Oramed Pharmaceuticals Inc  10.00 $ 61.173  Millions$ 6.119  Millions
Boundless Bio Inc   9.93 $ 117.570  Millions$ 11.845  Millions
Innoviva Inc   9.83 $ 476.513  Millions$ 48.471  Millions
Abivax Sa  9.80 $ 692.017  Millions$ 70.584  Millions
Medicinova Inc   9.76 $ 32.563  Millions$ 3.337  Millions
Vtv Therapeutics Inc   9.72 $ 98.504  Millions$ 10.131  Millions
Astria Therapeutics Inc   9.68 $ 227.721  Millions$ 23.517  Millions
Merus N v   9.52 $ 826.363  Millions$ 86.800  Millions
Lite Strategy Inc   9.47 $ 10.113  Millions$ 1.068  Millions
Bicycle Therapeutics Plc  9.36 $ 648.325  Millions$ 69.282  Millions
Abeona Therapeutics Inc   9.34 $ 207.117  Millions$ 22.180  Millions
An2 Therapeutics Inc   9.28 $ 61.921  Millions$ 6.675  Millions
Mineralys Therapeutics Inc   9.25 $ 217.597  Millions$ 23.520  Millions
Silo Pharma Inc  9.22 $ 5.866  Millions$ 0.636  Millions
Bioage Labs Inc   9.21 $ 225.651  Millions$ 24.493  Millions

Date modified: 2026-09-18T13:11:06+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.